The government held a consultative meeting with private sector stakeholders on Thursday to promote the use of AI in drug development in response to the intensifying global competition in the ...
The lab is using AI to analyze complex biomedical data to improve drug development for many diseases, including MS and ...
AI-leveraged drug development has become an $18 billion industry, but companies in the sector are experiencing some hardships. Beyond efforts to convenience investors their drugs are safe and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback